Airain Ltd’s West Pharmaceutical WST Stock Holding History

Airain Ltd’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-13,985	Closed	-$1.04M	–	870
2016 Q3	$1.04M	Sell	13,985 -7,442	-35%	-$591K	0.06%	322
2016 Q2	$1.63M	Buy	+21,427	New	+$1.56M	0.09%	246
2014 Q4	–	Sell	-8,352	Closed	-$374K	–	939
2014 Q3	$374K	Sell	8,352 -7,883	-49%	-$335K	0.03%	521
2014 Q2	$685K	Sell	16,235 -2,932	-15%	-$126K	0.06%	346
2014 Q1	$844K	Buy	+19,167	New	+$902K	0.15%	241

Other funds holding WST

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Airain Ltd's WST Position: Q4 2016 in Review

Airain Ltd sold out of West Pharmaceutical (WST) in Q4 2016, closing a stake of 13,985 shares — an estimated $1.04M sold.

Airain Ltd first reported a position in WST in Q1 2014 and held it in 5 quarters. The position peaked at $1.63M in Q2 2016. 288 funds tracked by Wall St. Rank hold WST as of Q4 2016.

Airain Ltd reported no remaining West Pharmaceutical position as of Q4 2016 after selling out during the quarter.
Airain Ltd sold 13,985 West Pharmaceutical shares in Q4 2016, an estimated $1.04M.
Airain Ltd first reported a position in West Pharmaceutical in Q1 2014 and held it in 5 quarters.
Airain Ltd's West Pharmaceutical position peaked at $1.63M in Q2 2016.
288 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2016.

Based on Airain Ltd's 13F filing for Q4 2016, filed 10 Feb 2017.